BN Business News
Add your company to Business Communicator →

Business · 18/07/2005Updated: 10/17/2026 · 1 min read

FDA Approves New Animal Drug for Skeletal Marking of Finfish Fry and Fingerlings

Summary

The FDA has approved a supplemental new animal drug application filed by Pfizer, Inc. for the use of oxytetracycline hydrochloride soluble powder in marking finfish fry and fingerlings through immersion.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →